-inc-logo-1200x675.png){kind=logo}
Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report) shares dropped 0.6% during mid-day trading on Friday . The stock traded as low as $7.00 and last traded at $7.21. Approximately 11,210,615 shares were traded during mid-day trading, an increase of 232% from the average daily volume of 3,376,665 shares. The stock had previously closed at $7.25.
Mind Medicine (MindMed) Stock Down 0.6 %
The company’s 50 day moving average price is $8.37 and its 200-day moving average price is $6.84.
About Mind Medicine (MindMed)
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Featured Stories
- Five stocks we like better than Mind Medicine (MindMed)
- Business Services Stocks Investing
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- ESG Stocks, What Investors Should Know
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- Stock Analyst Ratings and Canadian Analyst Ratings
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
